AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27236320
Drug: Voriconazole 50
RxNorm normalized name: voriconazole 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole 50 mg intravenous
Trial: 27236320
Drug: Voriconazole 400
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voriconazole 400 mg intravenous
Trial: 27236320
Drug: Voriconazole (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole (both doses)
Trial: 25007675
Drug: Local packing
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local packing of Nasopore combined with hemocoagulase injection (1 U of hemocoagulase dissolved in 0.5 ml saline)
Trial: 25007675
Drug: Local packing
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local packing of Nasopore combined with saline injection (0.5 ml saline)
Trial: 20926013
Drug: multimodal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multimodal analgesia protocol (oral celecoxib and tramadol before and after surgery; intra‐articular injection of morphine, ropivacaine, adrenaline, and betamethasone during surgery)
Trial: 20926013
Drug: oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral and intra‐articular placebo
Trial: 12435158
Drug: Chloroquine and
RxNorm normalized name: chloroquine and proguanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine and 5-day regimen of primaquine at 15 mg/day
Trial: 11910651
Drug: Estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol valerate 2.0 mg/dienogest 2.0 mg (Climodien)
Trial: 11910651
Drug: Estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol valerate 2.0 mg/dienogest 3.0 mg (E2Val 2/DNG 3)
Trial: 11910651
Drug: Estradiol 2.0
RxNorm normalized name: Estradiol 2.083 microgram/hour prolonged-release vaginal ring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol 2.0 mg/estriol 1.0 mg/norethisterone acetate 1.0 mg (Kliogest)
Trial: 8478230
Drug: Strontium-89 (10.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strontium-89 (10.8 mCi single injection)
Trial: 3762845
Drug: Phenobarbital (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (combined loading and titration)
Trial: 3762845
Drug: More than
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More than one agent (including diazepam)
Trial: 23350933
Drug: Pay-for-performance program
RxNorm normalized name: Perform
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pay-for-performance program (P4P) providing A$40 and A$100 for diabetes and asthma treatment, and A$35 for cervical cancer screening.
Trial: 17395029
Drug: Insulin-Glucose Infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-Glucose Infusion
Trial: 11149435
Drug: Mechanical ventilation
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical ventilation with V(T) = 15 ml/kg ideal body weight on ZEEP
Trial: 11149435
Drug: Mechanical ventilation
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on ZEEP
Trial: 11149435
Drug: Mechanical ventilation
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on positive end‐expiratory pressure of 10 cm H2O
Trial: 1493837
Drug: Penicillin (Phenoxymethylpenicillin)
RxNorm normalized name: Penicillin V
DrugBank: Meticillin (DB01603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin (Phenoxymethylpenicillin) 250 mg t.i.d. for adults and 125 mg t.i.d. for children
Trial: 30537874
Drug: Animal-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal-assisted therapy as an adjunct to intensive family preservation services (n = 14)
Trial: 21905254
Drug: Pain group
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain group (n = 13) - resistance training during pain induced by injections of painful hypertonic saline
Trial: 21905254
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 14) - resistance training during a nonpainful condition with injection of isotonic saline
Trial: 17976337
Drug: Double-dose vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose vitamin D
Trial: 10496155
Drug: TETRAMUNE (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TETRAMUNE (combination vaccine of HibTITER and DTP)
Trial: 10496155
Drug: DTP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP and HibTITER administered concurrently (separate group)
Trial: 7570885
Drug: Intrarectal Quinimax®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal Quinimax® (20 mg/kg)
Trial: 7570885
Drug: Intramuscular Quinimax®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Quinimax® (12.5 mg/kg)
Trial: 7570885
Drug: Intramuscular Quinimax®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Quinimax®
Trial: 2668757
Drug: Single-dose ketoconazole
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose ketoconazole (400 mg)
Trial: 2668757
Drug: Single-dose ketoconazole
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose ketoconazole (800 mg)
Trial: 779006
Drug: Co-trimoxazole (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (320 mg trimethoprim and 1600 mg sulphamethoxazole daily for 10 days)
Trial: 779006
Drug: Nitrofurantoin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin (200 mg/day for 10 days)
Trial: 31985266
Drug: ALTENS four‐times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALTENS four‐times weekly for 6 weeks
Trial: 31985266
Drug: ALTENS two‐times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALTENS two‐times weekly for 12 weeks
Trial: 30888217
Drug: Pycnogenol (PYC)
DrugBank: Maritime pine extract (DB15786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (PYC) 50 mg per day for 4 months
Trial: 26883526
Drug: Pharmacist-assisted medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge
Trial: 28630194
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g intravenous fosfomycin disodium
Trial: 28630194
Drug: 8 g
RxNorm normalized name: Theranost 68 Ga Rgd
DrugBank: NODAGA-THERANOST Ga-68 (DB16940)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g intravenous fosfomycin disodium
Trial: 28630194
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g oral fosfomycin tromethamine
Trial: 23489710
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy administered by insulin pen
Trial: 23489710
Drug: More positive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More positive expectations of insulin therapy
Trial: 19180896
Drug: Calcipotriene 0.005%
RxNorm normalized name: CALCIPOTRIENE 0.005% OINT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriene 0.005% betamethasone dipropionate 0.064% ointment
Trial: 18322602
Drug: Fufang Biejia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fufang Biejia Ruangan tablet (FBRt)
Trial: 18322602
Drug: He Luo
RxNorm normalized name: HE-2200
DrugBank: HE-2200 (DB06257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: He Luo Shu Gan capsule (Control)
Trial: 12136475
Drug: Immunodepressive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunodepressive therapy
Trial: 12136475
Drug: Intravenous pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pulse therapy with cyclophosphamide
Trial: 12136475
Drug: Intravenous pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pulse therapy
Trial: 7573298
Drug: Climara patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Climara patch
Trial: 27977819
Drug: Feather-edge preparation
RxNorm normalized name: Gallus gallus feather
DrugBank: Gallus gallus feather (DB10420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feather-edge preparation
Trial: 23548118
Drug: Paeoniflorin (PAE)
RxNorm normalized name: Paeoniflorin
DrugBank: Peoniflorin (DB16288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paeoniflorin (PAE) + cervus and cucumis polypeptide injection (CCPI)
Trial: 22462231
Drug: Amino-polypeptide as
RxNorm normalized name: Heme iron polypeptide
DrugBank: Heme iron polypeptide (DB11067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino-polypeptide as a basic treatment
Trial: 19624787
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER (4 mg)
Trial: 9046249
Drug: Vancomycin 20
RxNorm normalized name: vancomycin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin 20 micrograms/mL and Gentamicin 8 micrograms/mL in the irrigating fluid
Trial: 7959572
Drug: OK-432 (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 (administered pre-operatively via hepatic artery)
Trial: 23595590
Drug: Topical zinc
RxNorm normalized name: bacitracin topical zinc compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical zinc oxide treatment
Trial: 23595590
Drug: Parenteral zinc,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral zinc, copper, and selenium combined
Trial: 21709199
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus vitamin D supplementation (1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily)
Trial: 19535421
Drug: Stearate-enriched plant
RxNorm normalized name: stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stearate-enriched plant sterol esters (3 g/d, 1 g three times per day with meals)
Trial: 9431633
Drug: Specific exercise
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific exercise treatment program involving training of deep abdominal muscles and co-activation of lumbar multifidus for 10 weeks
Trial: 9431633
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment as directed by treating practitioner
Trial: 3388875
Drug: sucralfate (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate (4 g/day)
Trial: 3388875
Drug: ranitidinhydrochloride (336
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidinhydrochloride (336 mg/day)
Trial: 3388875
Drug: ranitidinhydrochloride and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidinhydrochloride and pirenzepindihydrochloride (100 mg/day)
Trial: 31177181
Drug: Habitual daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Habitual daily physical activity (measured by total physical activity counts - TAC)
Trial: 18564231
Drug: tolterodine-ER 4
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine-ER 4 mg
Trial: 15331567
Drug: Oral trientine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trientine therapy for 7 weeks in diabetic rats
Trial: 15331567
Drug: Oral trientine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trientine treatment for 6 months in humans with type 2 diabetes
Trial: 15331567
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of Cu-selective transition metal chelator trientine
Trial: 10819335
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment (twice weekly for 6 months) with isoniazid 15 mg/kg/dose, rifampin 15 mg/kg/dose, and pyrazinamide 55 mg/kg/dose for 2 months, followed by isoniazid and rifampin only for 4 months.
Trial: 10819335
Drug: Daily treatment
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 g TOPICAL GEL [Acne defense Daily Treatment Serum Merle Norman]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily treatment (weekday) with isoniazid 10 mg/kg/day, rifampin 10 mg/kg/day, and pyrazinamide 25 mg/kg/day for 6 months.
Trial: 6352280
Drug: Adriamycin (ADM)
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin (ADM) 75 mg/m2, administered i.v. bolus every 3 weeks
Trial: 6352280
Drug: Carminomycin (CMM)
RxNorm normalized name: Dactinomycin
DrugBank: Dactinomycin (DB00970)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carminomycin (CMM) 20 mg/m2, administered i.v. bolus every 3 weeks
Trial: 31146774
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment at nine acupuncture points (GV20, EX-HN1, bilateral LI4, and ST36) twice a week for 12 weeks
Trial: 31146774
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture treatment at the same points with non-penetrating sham needles
Trial: 21375669
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol 400 µg
Trial: 21375669
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin 20 units
Trial: 19075271
Drug: Oregovomab (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oregovomab (2 mg infused over 20 minutes at weeks 0, 4, and 8, then every 12 weeks until recurrence or up to year 5)
Trial: 17848834
Drug: RAI+rhTSH (0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAI+rhTSH (0.45 mg of rhTSH prior to treatment)
Trial: 17848834
Drug: RAI (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAI (no rhTSH pre-treatment)
Trial: 15377348
Drug: ALA-PDT treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-PDT treatment
Trial: 11855664
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/day + Vitamin E 600 IU/day (G5)
Trial: 11855664
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/day (G4)
Trial: 25432877
Drug: Daily emtricitabine/tenofovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily emtricitabine/tenofovir
Trial: 24377213
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of acupuncture and moxibustion
Trial: 24377213
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (glucosamine sulfate capsules and joint cavity injections)
Trial: 14557011
Drug: Cyclogest vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclogest vaginal suppositories 400mg twice daily
Trial: 14557011
Drug: Crinone 8%
RxNorm normalized name: Crinone 8% Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8% vaginal gel once daily
Trial: 30564971
Drug: Pharmacy-led intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmacy-led intervention to improve medication adherence
Trial: 30564971
Drug: Belief About
RxNorm normalized name: Ora Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belief About Medicines Questionnaire-Specific
Trial: 27053383
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HS and MNP
Trial: 19597520
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no training or additional therapy)
Trial: 18455656
Drug: Soy (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy (50 g daily)
Trial: 18455656
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (3 g in 500 mL of water daily)
Trial: 18455656
Drug: Soy (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy (50 g daily) and Green tea (3 g daily)
Trial: 354615
Drug: Intravenous droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous droperidol (Inapsine)
Trial: 30573159
Drug: Annurca apple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annurca apple polyphenolic extract (AMS), 4 capsules/day for 24 weeks
Trial: 30573159
Drug: Placebo (maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin capsules)
Trial: 26655129
Drug: OAC-1 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC-1 group (1 week treatment with omeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg bid)
Trial: 26655129
Drug: OAC-2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC-2 group (2 weeks treatment with omeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg bid)
Trial: 26655129
Drug: OAC-1 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC-1 group (1 week treatment)
Trial: 26655129
Drug: OAC-2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC-2 group (2 weeks treatment)
Trial: 16513521
Drug: Dosing adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dosing adjusted for the source‐to‐target distance (DA group)
Trial: 16513521
Drug: Recommended dose
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended dose prescription protocol (S group)
Trial: 12602655
Drug: Antidepressant medication;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication; effectiveness assessed through factor analysis; specific dosage and duration not mentioned.
Trial: 11493096
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of saline spa water and UV‐B therapy (group C)
Trial: 9612329
Drug: L‐NMMA (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐NMMA (3 mg/kg over 10 min) during high sodium intake (250 mmol/day)
Trial: 9612329
Drug: L‐NMMA (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐NMMA (3 mg/kg over 10 min) during low sodium intake (77 mmol/day)
Trial: 8296408
Drug: Erythropoietin albumin-solution
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin albumin-solution
Trial: 7984241
Drug: Bisdioxopiperazines (topoisomerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisdioxopiperazines (topoisomerase II inhibitors) such as ICRF-193
Trial: 7984241
Drug: Caffeine (checkpoint-evading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (checkpoint-evading agent)
Trial: 19249998
Drug: Yoga program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga program (12-week, twice-weekly sessions including asanas and visama vritti pranayama)
Trial: 15078254
Drug: Plasmapheresis (37,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasmapheresis (37, 16, and 10 l annually)
Trial: 11966951
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) therapy for 2 years
Trial: 10325999
Drug: 2.5% topical
RxNorm normalized name: BP 2.5% Topical Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% topical aqueous phenylephrine
Trial: 10325999
Drug: 10% topical
RxNorm normalized name: BP 10% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% topical aqueous phenylephrine
Trial: 7584198
Drug: Cryo/Cuff (CC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryo/Cuff (CC)
Trial: 7584198
Drug: Ice therapy
RxNorm normalized name: Ice Therapy
DrugBank: Levomenthol (DB00825)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ice therapy (ICE)
Trial: 31096036
Drug: Fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/salmeterol (FP/SAL) 250/50 μg